106 related articles for article (PubMed ID: 8206274)
21. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells.
Menashi S; Dehem M; Souliac I; Legrand Y; Fridman R
Int J Cancer; 1998 Jan; 75(2):259-65. PubMed ID: 9462717
[TBL] [Abstract][Full Text] [Related]
22. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y
Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases in sterile corneal melts.
Geerling G; Joussen AM; Daniels JT; Mulholland B; Khaw PT; Dart JK
Ann N Y Acad Sci; 1999 Jun; 878():571-4. PubMed ID: 10415776
[No Abstract] [Full Text] [Related]
26. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
Sava G; Capozzi I; Bergamo A; Gagliardi R; Cocchietto M; Masiero L; Onisto M; Alessio E; Mestroni G; Garbisa S
Int J Cancer; 1996 Sep; 68(1):60-6. PubMed ID: 8895542
[TBL] [Abstract][Full Text] [Related]
27. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
[TBL] [Abstract][Full Text] [Related]
29. Gelatinase A and APP.
Miyazaki K; Funahashi K; Umeda M; Nakano A
Nature; 1994 Apr; 368(6473):695-6. PubMed ID: 8179718
[No Abstract] [Full Text] [Related]
30. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
Hayashi T; Stetler-Stevenson WG; Fleming MV; Fishback N; Koss MN; Liotta LA; Ferrans VJ; Travis WD
Am J Pathol; 1996 Oct; 149(4):1241-56. PubMed ID: 8863673
[TBL] [Abstract][Full Text] [Related]
31. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
32. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
34. The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A.
Menashi S; Vlodavsky I; Ishai-Michaeli R; Legrand Y; Fridman R
FEBS Lett; 1995 Mar; 361(1):61-4. PubMed ID: 7890041
[TBL] [Abstract][Full Text] [Related]
35. Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle.
Goldberg MJ; Moses MA; Tsang PC
J Anim Sci; 1996 Apr; 74(4):849-57. PubMed ID: 8728007
[TBL] [Abstract][Full Text] [Related]
36. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture.
Abdel Wahab N; Mason RM
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):777-83. PubMed ID: 9003362
[TBL] [Abstract][Full Text] [Related]
37. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Nakagawa H; Yagihashi S
Jpn J Cancer Res; 1994 Sep; 85(9):934-8. PubMed ID: 7961122
[TBL] [Abstract][Full Text] [Related]
38. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
39. Gelatinases and metalloproteinase inhibitor secreted by murine colonic carcinoma cells with differing metastatic potential.
Kishi J; Tanaka R; Koiwai O; Yamagata S; Numata Y; Hayakawa T; Shimizu S
Cell Biol Int; 1994 Mar; 18(3):165-70. PubMed ID: 8019490
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinases and metastatic cancer.
Cockett MI; Murphy G; Birch ML; O'Connell JP; Crabbe T; Millican AT; Hart IR; Docherty AJ
Biochem Soc Symp; 1998; 63():295-313. PubMed ID: 9513731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
